The Minnesota Cognitive Acuity Screen (MCAS) was developed and statistically validated by leading scientists and physicians for Univita to help identify early symptoms of dementia, including Alzheimer's Disease. The MCAS is a much-needed tool to bridge the gap between expensive medical evaluations and a physician's best guess.
This fifteen-minute screen correctly identifies cognitively impaired and unimpaired subjects with 98.1% accuracy, i.e. an error rate of only 1.9%. Other tests have error rates of 10% or more. The MCAS is flexible; it can be administered telephonically or face to face, with minimal false positives or false negatives, and without loss of reliability.
25% to 50% of applicants with cognitive impairments are not detected by memory testing alone. The MCAS is does in-depth testing in a variety of areas of cognition, including:
- Short-term memory
- Reasoning, orientation